Skip to content

Wednesday, October 28, 2026

Data from SEC filings, checked daily

Public filings, plainly told

About Method Sources Newsletter

Insider tradingForm 4

10x Genomics, Inc. (TXG) Insider Trading

12 open-market trades reported since Aug 13, 2026: 0 purchases worth $0 and 12 sales worth $12.2M.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Serge Saxonov	CEO	0	$0	3	$3.87M	Sep 24, 2026
Shehnaaz Suliman	Director	0	$0	2	$605K	Sep 24, 2026
Adam Taich	CFO	0	$0	2	$4.08M	Sep 11, 2026
John R. Stuelpnagel	Director	0	$0	2	$2.39M	Sep 8, 2026
Benjamin J. Hindson	See Remarks	0	$0	1	$871K	Aug 26, 2026
Sarah A. Teichmann	Director	0	$0	2	$432K	Aug 17, 2026

All trades

TXG insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Sep 24	Sep 22	Serge SaxonovCEO	CEO	▼ SELL10b5-1	25,000	81.22	$2.03M	−2.3%		Form 4 ↗
Sep 24	Sep 22	Shehnaaz SulimanDirector	Director	▼ SELL10b5-1	5,723	81.19	$465K	−19%		Form 4 ↗
Sep 11	Sep 9	Adam TaichCFO	CFO	▼ SELL10b5-1	46,388	64.57	$3.00M	−13%		Form 4 ↗
Sep 8	Sep 3	John R. StuelpnagelDirector	Director	▼ SELL	20,000	61.75	$1.24M	−5.7%		Form 4 ↗
Aug 28	Aug 26	Serge SaxonovCEO	CEO	▼ SELL10b5-1	10,486	63.69	$668K	−1.0%		Form 4 ↗
Aug 26	Aug 24	Serge SaxonovCEO	CEO	▼ SELL	18,545	63.02	$1.17M	−1.7%		Form 4 ↗
Aug 26	Aug 24	Adam TaichCFO	CFO	▼ SELL	17,166	63.02	$1.08M	−4.5%		Form 4 ↗
Aug 26	Aug 24	Benjamin J. HindsonSee Remarks	See Remarks	▼ SELL	13,818	63.02	$871K	−2.8%		Form 4 ↗
Aug 26	Aug 24	Shehnaaz SulimanDirector	Director	▼ SELL10b5-1	2,207	63.65	$140K	−7.0%		Form 4 ↗
Aug 17	Aug 13	Sarah A. TeichmannDirector	Director	▼ SELL10b5-1	5,278	57.29	$302K	−15%		Form 4 ↗
Aug 17	Aug 14	Sarah A. TeichmannDirector	Director	▼ SELL10b5-1	2,273	57.15	$130K	−7.5%		Form 4 ↗
Aug 13	Aug 11	John R. StuelpnagelDirector	Director	▼ SELL	20,000	57.75	$1.16M	−5.4%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings